Stoke Therapeutics, Inc. Common Stock (STOK) is a publicly traded Healthcare sector company. As of May 20, 2026, STOK trades at $30.76 with a market cap of $1.81B and a P/E ratio of -10.54. STOK moved +1.13% today. Year to date, STOK is -6.93%; over the trailing twelve months it is +201.44%. Its 52-week range spans $5.35 to $40.22. Analyst consensus is strong buy with an average price target of $46.71. Rallies surfaces STOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes STOK SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $30.76 |
| Market Cap | $1.81B |
| P/E Ratio | -10.54 |
| EPS | $-2.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.22 |
| 52-Week Low | $5.35 |
| Volume | 506.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.08M |
| Net Income | $-169.77M |
| Gross Margin | 0.00% |
8 analysts cover STOK: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.71.